On October 19, 2016 the Biotech RusFrance meeting was held in the Hypercube of the Skolkovo Innovation Center. The event was dedicated to the 50th anniversary of academic and technological cooperation between Russia and France. Science and business representatives discussed prospective ways of development of biotechnology projects.
Data MATRIX, represented by Director of Business Development Anfisa Shakhova, participated in a roundtable discussion «New Opportunities in Development of Drugs, Test-systems and Biotechnologies: Sharing Experience». Representatives of Sanofi, 3D Bioprinting Solutions, Human Stem Cells Institute, and Marlin Biotech also took part in the session moderated by Founder of Marchmont Capital Partners Kendrick White.
During the roundtable the participants discussed foreign-market experience of the companies. Anfisa Shakhova shared some details of Data MATRIX work with foreign sponsors and outlined the company’s development plans in the European region. The speakers also touched upon intellectual property protection issues.
Today, the biotechnology market remains one of the most dynamically developing and attractive for business. The experience gained by France in this field is especially valuable in terms of expertise in development of biotech projects from research stages to commercial success